Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness

Simon R Procter and colleagues explore the global health impact and cost-effectiveness of maternal immunisation against Group B Streptococcus.

Related Keywords

United Kingdom ,United States ,South Africa ,Gambia ,Netherlands ,America ,Clint Pecenka ,Ranju Baral ,London School Of Hygiene Tropical Medicine ,Sustainable Development Goal ,World Bank Region ,Scientific Advisory Group ,Melinda Gates Foundation ,World Bank ,World Health Organisation ,Groupb Streptococcus ,Product Development For Vaccines Advisory Committee ,Groupb Streprococcus ,Product Characteristics ,Creative Commons Attribution License ,London School ,Tropical Medicine ,Melinda Gates ,World Health ,Full Value ,Vaccines Assessment ,Gross Domestic Product ,Product Development ,Vaccines Advisory Committee ,United Nations World Populations Prospects ,United States Dollars ,Tetanus Toxoid ,Defeating Meningitis ,Saharan Africa ,Sustainable Development ,Vaccine Assessment ,Vaccination And Immunization ,Vaccines ,Stillbirths ,Economic Analysis ,Vaccine Development ,Cost Effectiveness Analysis ,Medical Risk Factors ,Preterm Birth ,